Intercept Pharmaceuticals Buy Hold or Sell Recommendation
| ICPTDelisted Stock | USD 10.31 0.16 1.53% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Intercept Pharmaceuticals is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Intercept Pharmaceuticals given historical horizon and risk tolerance towards Intercept Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Intercept Pharmaceuticals, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. Note, we conduct extensive research on individual companies such as Intercept and provide practical buy, sell, or hold advice based on investors' constraints. Intercept Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Intercept |
Execute Intercept Pharmaceuticals Buy or Sell Advice
The Intercept recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Intercept Pharmaceuticals. Macroaxis does not own or have any residual interests in Intercept Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Intercept Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Intercept Pharmaceuticals Trading Alerts and Improvement Suggestions
| Intercept Pharmaceuticals is not yet fully synchronised with the market data | |
| Intercept Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Intercept Pharmaceuticals has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the previous year's revenue of 285.71 M. Net Loss for the year was (174.86 M) with profit before overhead, payroll, taxes, and interest of 284.73 M. | |
| Intercept Pharmaceuticals currently holds about 404.78 M in cash with (26.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 81.0% of the company shares are owned by institutional investors |
Intercept Pharmaceuticals Returns Distribution Density
The distribution of Intercept Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Intercept Pharmaceuticals' future price movements. The chart of the probability distribution of Intercept Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Intercept Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Intercept Pharmaceuticals returns is essential to provide solid investment advice for Intercept Pharmaceuticals.
| Mean Return | -0.78 | Value At Risk | -8.32 | Potential Upside | 5.23 | Standard Deviation | 5.20 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Intercept Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Payment of 357 shares by Christian Weyer of Intercept Pharmaceuticals subject to Rule 16b-3 [view details]
Intercept Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Intercept . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Intercept Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Intercept Pharmaceuticals? Buying financial instruments such as Intercept Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Intercept Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities - Regulated Electric Thematic Idea Now
Utilities - Regulated Electric
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities - Regulated Electric theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities - Regulated Electric Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Intercept Stock
If you are still planning to invest in Intercept Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intercept Pharmaceuticals' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |